News

MMS Holdings Wins 2021 Scrip Award for Best Contract Research Organization

Best Contract Research Organization

CANTON, Mich. (12/8/2021) – MMS Holdings, a data-focused CRO, is pleased to announce its selection as Best Contract Research Organization – Specialist Providers in the 2021 Scrip Awards.  

The Scrip Awards, held annually by London-based Informa Pharma Intelligence, honors outstanding achievements of organizations in the pharmaceutical, biotech and allied industries.  

The award for Best Contract Research Organization-Specialist Provider recognizes MMS for exceeding Sponsor expectations, bringing innovations to the industry, improving data quality and transparency, and streamlining data collection and reporting through the Decentralized Trials and Research Alliance (DTRA).  

“Our mission is to deliver high-quality service and technology solutions – rooted in strong science and decades of regulatory experience – that will assist our clients in developing and marketing life-changing therapies to positively improve lives worldwide,” said Michelle Gayari, Executive Vice President of Global Operational Excellence and Innovation, MMS. “We are thrilled to win this award and be recognized as a leader in the data, regulatory, and transparency space by Pharma Intelligence.”  

Over the past five years, MMS has completed more than 50 submissions for drug approval, gained an FDA fast-track designation for a non-opioid painkiller, and offered a seven-figure award toward a COVID-19 vaccine. 

“Attending the Scrip Awards with my EU-based colleagues on behalf of our #OneMMS global team was a delight after the past year we’ve had,” said Alan Nicolle, Senior Director of European Union and South Africa Operations, MMS. “It was great to see a gathering of individuals and organizations dedicated to improving healthcare and innovating the industry.” 

The full list of award winners is available at Winners of the 2021 Scrip Awards on the Informa Pharma Intelligence website. 

ABOUT MMS 

MMS is an award-winning, data-focused CRO that supports the pharmaceutical and biotech industries with a proven, scientific approach to complex trial data and regulatory submission challenges. Strong industry experience and a data-driven approach to drug development make MMS a valuable CRO partner, creating compelling submissions that meet rigorous regulatory standards. With a global footprint across four continents, MMS maintains a 97 percent customer satisfaction rating, and the company was named Most Outstanding CRO in the 2019 Biotechnology Awards and Best Global CRO in the 2018 International Life Sciences Awards. For more information, visit www.mmsholdings.com or follow MMS on LinkedIn.  

ABOUT INFORMA PHARMA INTELLIGENCE 

Informa Pharma intelligence powers a full suite of analysis products — Scrip, Datamonitor Healthcare, Citeline, Medtrack, Sitetrove, Pharmaprojects, Biomedtracker, Meddevicetracker, Pink Sheet, and In Vivo – to deliver the data needed by the pharmaceutical and biomedical industry to make decisions and create real-world opportunities for growth. For more information, visit pharmaintelligence.informa.com. Informa is a leading international Information Services, Advanced Knowledge, Exhibitions and Events Group. It helps commercial, professional and academic communities work smarter and make better decisions faster, through specialist content and intelligence, and opportunities to connect and learn. For more information, please visit www.informa.com 

Media Contact 

Avery Zimmerman
Media@mmsholdings.com

Back to MMS News